Krishna Institute of Medical Sciences · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Nasik hospital ramp-up has been slow due to delayed insurance and corporate empanelment (accounts for 60% of volumes in Maharashtra cluster). Similar 9-12 month delays expected for Bangalore launch. Patients are choosing alternative hospitals rather than navigate cumbersome reimbursement processes.
Nasik has 2-3 specialties still pending doctor onboarding, contingent on insurance empanelment completion. This creates a chicken-and-egg problem where insurance is needed to attract specialists, but specialists are needed to qualify for insurance.
Company is in aggressive expansion mode with 5 new hospitals simultaneously ramping. EBITDA margin compressed to 22.7% vs 26.6% year-ago. Management deflected when asked for peak revenue potential and steady-state ROC targets by cluster, providing only directional guidance.
AP cluster margins impacted in Q1 due to doctor onboarding costs at Kolar (commissioned July 1) and renovation delays at QNR acquired hospital. Renovation completion and subsequent ramp-up delayed into Q2-Q3.
